Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Nov;29(11):2335–2344. doi: 10.3201/eid2911.230753

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.

PMC Copyright notice

Adjusted odds ratios between antimicrobial resistance and lethality by appropriate empirical antibiotic treatment (considering the definition of appropriate empirical treatment given by each author) in systematic review and meta-analysis of deaths attributable to antimicrobial resistance, Latin America. Death-R indicates death in the resistant group; Death-S indicates death in the susceptible group. Error bars indicate 95% CIs. CR-AB, carbapenem-resistant Acinetobacter baumannii; CRE, carbapenem-resistant Enterobacterales; CR-PA, carbapenem-resistant Pseudomonas aeruginosa; ESBL-E, extended-spectrum β-lactamase–producing Enterobacterales; MDR-GNB, multidrug-resistant gram-negative bacilli (including ESBL-E, CRE, CR-PA, CR-AB); MDRO, multidrug-resistant organisms (including MRSA, vancomycin-resistant Enterococcus, ESLB-E, CRE, CR-PA, CR-AB); MRSA, methicillin-resistant Staphylococcus aureus; NR, not reported; OR, odds ratio.